Trial Profile
A study to evaluate the safety and efficacy of Tocilizumab in patients with refractory aortitis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Sep 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Aortitis
- Focus Adverse reactions; Therapeutic Use
- 10 Sep 2015 New trial record